메뉴 건너뛰기




Volumn 15, Issue 1, 2006, Pages 69-75

Adverse outcome and resistance to adjuvant antiestrogen therapy in node-positive postmenopausal breast cancer patients - The role of p53

Author keywords

Antiestrogen; Breast cancer; p53; Predictive factor; Prognosis

Indexed keywords

ANTIESTROGEN; ESTROGEN RECEPTOR; PROTEIN P53; TAMOXIFEN; TOREMIFENE;

EID: 32244436889     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2005.04.004     Document Type: Article
Times cited : (9)

References (23)
  • 1
    • 0033885192 scopus 로고    scopus 로고
    • TP53 mutation is an independent prognostic marker for poor outcome in both node-negative and node-positive breast cancer
    • J. Overgaard M. Yilmaz P. Guldberg L.L. Hansen J. Alsner TP53 mutation is an independent prognostic marker for poor outcome in both node-negative and node-positive breast cancer Acta Oncol 39 2000 327-333
    • (2000) Acta Oncol , vol.39 , pp. 327-333
    • Overgaard, J.1    Yilmaz, M.2    Guldberg, P.3    Hansen, L.L.4    Alsner, J.5
  • 2
    • 0029908595 scopus 로고    scopus 로고
    • Tp53 and MYC gene alternations independently predict poor prognosis in breast cancer patients
    • E.M. Berns J.G. Klijn M. Smid et al. Tp53 and MYC gene alternations independently predict poor prognosis in breast cancer patients Gene Chromosome Cancer 16 1996 170-179
    • (1996) Gene Chromosome Cancer , vol.16 , pp. 170-179
    • Berns, E.M.1    Klijn, J.G.2    Smid, M.3
  • 3
    • 0034029990 scopus 로고    scopus 로고
    • P53 determination alongside classical prognostic factors in node-negative breast cancer: An evaluation at more than 10-year follow-up
    • J.M. Ferrero A. Ramaioli J.L. Formento et al. P53 determination alongside classical prognostic factors in node-negative breast cancer: an evaluation at more than 10-year follow-up Ann Oncol 11 2000 393-397
    • (2000) Ann Oncol , vol.11 , pp. 393-397
    • Ferrero, J.M.1    Ramaioli, A.2    Formento, J.L.3
  • 4
    • 0034651899 scopus 로고    scopus 로고
    • The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma. A multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years
    • W. Reed E. Hannisdal P.J. Boehler S. Gundersen H. Host J.M. Nesland The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma. A multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years Cancer 88 2000 804-813
    • (2000) Cancer , vol.88 , pp. 804-813
    • Reed, W.1    Hannisdal, E.2    Boehler, P.J.3    Gundersen, S.4    Host, H.5    Nesland, J.M.6
  • 5
    • 3843067789 scopus 로고    scopus 로고
    • Proliferation rate, hormone receptor status and p53 expression in skeletal metastasis of breast carcinoma
    • R. Wedin L. Skoog H.C.F. Bauer Proliferation rate, hormone receptor status and p53 expression in skeletal metastasis of breast carcinoma Acta Oncol 5 2004 460-466
    • (2004) Acta Oncol , vol.5 , pp. 460-466
    • Wedin, R.1    Skoog, L.2    Bauer, H.C.F.3
  • 6
    • 0030951877 scopus 로고    scopus 로고
    • bcl-2, p53 and response to tamoxifen in estrogen receptor-positive metastatic breast cancer
    • A Southwest Oncology Group study
    • R.M. Elledge S. Green L. Howes et al. bcl-2, p53 and response to tamoxifen in estrogen receptor-positive metastatic breast cancer. A Southwest Oncology Group study J Clin Oncol 115 1997 1916-1922
    • (1997) J Clin Oncol , vol.115 , pp. 1916-1922
    • Elledge, R.M.1    Green, S.2    Howes, L.3
  • 7
    • 0031919283 scopus 로고
    • P53 accumulation and response to adjuvant chemotherapy in premenopausal women with node-negative early breast cancer
    • P.C. Clahsen C.J. van de Velde C. Duval et al. P53 accumulation and response to adjuvant chemotherapy in premenopausal women with node-negative early breast cancer J Clin Oncol 16 1988 470-479
    • (1988) J Clin Oncol , vol.16 , pp. 470-479
    • Clahsen, P.C.1    van de Velde, C.J.2    Duval, C.3
  • 8
    • 0034667952 scopus 로고    scopus 로고
    • HER-2/neu and p53 expression versus tamoxifen resistance in estrogen receptor-positive, node-positive breast cancer
    • D.A. Berry H.B. Musss A.D. Thor L. Dressler et al. HER-2/neu and p53 expression versus tamoxifen resistance in estrogen receptor-positive, node-positive breast cancer J Clin Oncol 20 2000 3471-3479
    • (2000) J Clin Oncol , vol.20 , pp. 3471-3479
    • Berry, D.A.1    Musss, H.B.2    Thor, A.D.3    Dressler, L.4
  • 9
    • 2942594508 scopus 로고    scopus 로고
    • Mutation and accumulation of p53 related to results of adjuvant therapy of postmenopausal breast cancer patients
    • M. Stenmark Askmalm J. Carstensen B. Nordenskjöld et al. Mutation and accumulation of p53 related to results of adjuvant therapy of postmenopausal breast cancer patients Acta Oncol 3 2004 235-244
    • (2004) Acta Oncol , vol.3 , pp. 235-244
    • Stenmark Askmalm, M.1    Carstensen, J.2    Nordenskjöld, B.3
  • 10
    • 0032548879 scopus 로고    scopus 로고
    • No significant predictive value of c-erbB-2 or p53 expression regarding sensitivity to primary chemotherapy and radiotherapy in breast cancer
    • S. Rozan A. Vincent-Salomon B. Zafrani et al. No significant predictive value of c-erbB-2 or p53 expression regarding sensitivity to primary chemotherapy and radiotherapy in breast cancer Int J Cancer 79 1998 27-33
    • (1998) Int J Cancer , vol.79 , pp. 27-33
    • Rozan, S.1    Vincent-Salomon, A.2    Zafrani, B.3
  • 11
    • 0035166427 scopus 로고    scopus 로고
    • Prognostic value of TP53 gene mutations in adjuvant treated breast cancer patients
    • B.L. Powell S. Bydder F. Grieu et al. Prognostic value of TP53 gene mutations in adjuvant treated breast cancer patients Breast Cancer Res Treat 1 2001 65-68
    • (2001) Breast Cancer Res Treat , vol.1 , pp. 65-68
    • Powell, B.L.1    Bydder, S.2    Grieu, F.3
  • 12
    • 0031982783 scopus 로고    scopus 로고
    • p53 protein accumulation predicts poor response to tamoxifen therapy of patients with recurrent breast cancer
    • E.M. Berns J.G. Klijn W.L. van Putten et al. p53 protein accumulation predicts poor response to tamoxifen therapy of patients with recurrent breast cancer J Clin Oncol 16 1998 121-127
    • (1998) J Clin Oncol , vol.16 , pp. 121-127
    • Berns, E.M.1    Klijn, J.G.2    van Putten, W.L.3
  • 13
    • 0035879210 scopus 로고    scopus 로고
    • Value of epidermal growth factor receptor, HER2, p53, and steroid receptors in predicting efficacy of tamoxifen in high-risk postmenopausal breast patients
    • A.S. Knoop S.M. Bentzen M.M. Nielsen B.B. Rasmussen C. Rose Value of epidermal growth factor receptor, HER2, p53, and steroid receptors in predicting efficacy of tamoxifen in high-risk postmenopausal breast patients J Clin Oncol 19 2001 3376-3384
    • (2001) J Clin Oncol , vol.19 , pp. 3376-3384
    • Knoop, A.S.1    Bentzen, S.M.2    Nielsen, M.M.3    Rasmussen, B.B.4    Rose, C.5
  • 14
    • 0029863353 scopus 로고    scopus 로고
    • p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast patients
    • R. Silvestrini E. Benini S. Veneroni et al. p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast patients J Clin Oncol 14 1996 1604-1610
    • (1996) J Clin Oncol , vol.14 , pp. 1604-1610
    • Silvestrini, R.1    Benini, E.2    Veneroni, S.3
  • 15
    • 0029143982 scopus 로고
    • Biological and clinical role of angiogenesis in breast cancer
    • G. Gasparini Biological and clinical role of angiogenesis in breast cancer Breast Cancer Res Treat 36 1995 103-107
    • (1995) Breast Cancer Res Treat , vol.36 , pp. 103-107
    • Gasparini, G.1
  • 16
    • 0029889029 scopus 로고    scopus 로고
    • Determination of angiogenesis adds information to estrogen receptor status in predicting the efficacy of adjuvant tamoxifen in node-positive breast cancer patients
    • G. Gasparini S.B. Fox P. Verderio E. Bonoldi et al. Determination of angiogenesis adds information to estrogen receptor status in predicting the efficacy of adjuvant tamoxifen in node-positive breast cancer patients Clin Cancer Res 2 1996 1191-1198
    • (1996) Clin Cancer Res , vol.2 , pp. 1191-1198
    • Gasparini, G.1    Fox, S.B.2    Verderio, P.3    Bonoldi, E.4
  • 17
    • 0035751937 scopus 로고    scopus 로고
    • Assessing TP53 status in human tumours to evaluate clinical outcome
    • S. Soussi C. Beroud Assessing TP53 status in human tumours to evaluate clinical outcome Nat Rev Cancer 1 2001 233-240
    • (2001) Nat Rev Cancer , vol.1 , pp. 233-240
    • Soussi, S.1    Beroud, C.2
  • 18
    • 0030058617 scopus 로고    scopus 로고
    • The p53 gene in breast cancer: Prognostic value of complementary DNA sequencing versus immunohistochemistry
    • S. Sjögren M. Inganäs T. Norberg et al. The p53 gene in breast cancer: Prognostic value of complementary DNA sequencing versus immunohistochemistry J Natl Cancer Inst 3 1996 173-182
    • (1996) J Natl Cancer Inst , vol.3 , pp. 173-182
    • Sjögren, S.1    Inganäs, M.2    Norberg, T.3
  • 19
    • 0028875410 scopus 로고
    • Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy
    • J. Bergh T. Norberg S. Sjögren A. Lindgren L. Holmberg Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy Nat Med 10 1995 1029-1035
    • (1995) Nat Med , vol.10 , pp. 1029-1035
    • Bergh, J.1    Norberg, T.2    Sjögren, S.3    Lindgren, A.4    Holmberg, L.5
  • 20
    • 0026747130 scopus 로고
    • Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: Results of prospective Southwest Oncology Group study
    • P.M. Ravdin S. Green T.M. Dorr et al. Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: Results of prospective Southwest Oncology Group study J Clin Oncol 10 1992 1284-1291
    • (1992) J Clin Oncol , vol.10 , pp. 1284-1291
    • Ravdin, P.M.1    Green, S.2    Dorr, T.M.3
  • 21
    • 0034667858 scopus 로고    scopus 로고
    • Safety and efficacy results of a randomized trial comparing adjuvant toremifene and tamoxifen in postmenopausal patients with node-positive breast cancer
    • K. Holli R. Valavaara G. Blanco et al. Safety and efficacy results of a randomized trial comparing adjuvant toremifene and tamoxifen in postmenopausal patients with node-positive breast cancer J Clin Oncol 20 2000 3487-3494
    • (2000) J Clin Oncol , vol.20 , pp. 3487-3494
    • Holli, K.1    Valavaara, R.2    Blanco, G.3
  • 22
    • 0029903614 scopus 로고    scopus 로고
    • Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer
    • Swedish Breast Cancer Cooperative Group
    • Swedish Breast Cancer Cooperative Group Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer J Natl Cancer Inst 88 1996 1543-1549
    • (1996) J Natl Cancer Inst , vol.88 , pp. 1543-1549
  • 23
    • 0032537396 scopus 로고    scopus 로고
    • Tamoxifen for early breast cancer: An overview of the randomized trials
    • Early Breast Cancer Trialists' Collaborative Group
    • Early Breast Cancer Trialists' Collaborative Group Tamoxifen for early breast cancer: An overview of the randomized trials Lancet 351 1998 1451-1467
    • (1998) Lancet , vol.351 , pp. 1451-1467


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.